Wilkinson Stekloff served as lead trial counsel for Altria Group, Inc. in an adversarial administrative proceeding before the FTC. The FTC alleged that Altria and JUUL Labs, Inc. (JLI) violated the antitrust laws through Altria’s purchase of a minority interest in JLI and was seeking to require Altria to divest. On February 24, 2022, a ruling by Chief Administrative Law Judge D. Michael Chappell dismissed in their entirety claims by the FTC that Altria and JLI violated antitrust laws through Altria’s $12.8 billion purchase of a 35% interest in JLI. The FTC sought to require Altria to divest its interest in JLI in a three-week-long adversarial administrative proceeding last summer. At trial, Beth Wilkinson handled opening statements and examined multiple high-profile witnesses, including Altria’s current and former CEO, Altria’s general counsel, and both sides’ economic experts. Moira Penza led the presentation of the scientific evidence and examined Altria’s scientists. The Wilkinson Stekloff trial team also …
2021 Year In Review
WASHINGTON — In 2021, despite ongoing pandemic-related delays and challenges, the Wilkinson Stekloff team continued to litigate with the intensity and success that has cemented our reputation as the leading trial boutique in the country. In a year where trials remained scarce, WS tried two high-profile cases in 2021: WS served as lead trial counsel for Altria Group, Inc. in an adversarial administrative proceeding before the FTC. The FTC alleged that Altria and JLI violated antitrust laws through Altria’s purchase of a minority interest in JLI. At trial, Founding Partner Beth Wilkinson handled opening statements and examined multiple high-profile witnesses, including Altria’s current and former CEO, Altria’s general counsel, and both sides’ economic experts. WS Partner Moira Penza examined Altria’s scientists, and WS Partner James Rosenthal played a central role in strategy and legal briefing. After a single day of deliberation in October 2021, a jury delivered the first-ever verdict for Monsanto in litigation over whether the herbicide Roundup causes …
Crain’s New York Selects Partners Moira Penza and Ralia Polechronis as “Notable Women in Law”
WASHINGTON, D.C. — Wilkinson Stekloff is pleased to congratulate Partners Moira Penza and Ralia Polechronis on being named 2022 Notable Women in Law by Crain’s New York Business. The elite list of 119 lawyers includes women in all areas of law in New York City and surrounding counties who have been practicing for at least ten years and have attained a leadership role at their firms. Crain’s writes that honorees were chosen “not only for their skills and accomplishments in the courtroom, but for their leadership outside of it.” Moira Penza is an accomplished litigator with a record of success winning high-stakes civil and criminal trials. Her work has been recognized through industry accolades such as Bloomberg Law’s 2021 They’ve Got Next: The 40 Under 40; Benchmark Litigation’s 2021 40 and Under Hot List; and Law 360’s list of 2020 Rising Stars in the prestigious “Trials” category. Moira is a lifelong …
Wilkinson Stekloff Delivers Pre-Trial Win for Medtronic and Covidien in Hernia Mesh Litigation
A U.S. District Court Judge handed down a decisive victory for Medtronic and Covidien in litigation arising from claims that one of their hernia mesh products has design and manufacturing defects, and that the company provided inadequate warnings about the risks of the hernia mesh. Wilkinson Stekloff Founding Partner Brian Stekloff led the victory in Northrup v. Covidien (C.D. Cal.) by obtaining key admissions from Plaintiff’s expert that were quoted extensively in the Court’s opinion dismissing the case. Brian Stekloff also led oral argument before Judge Dean Pregerson on Defendants’ motions to exclude the opinions of Plaintiff’s expert and for summary judgment. Judge Pregerson agreed with Defendants’ arguments, and, on November 24, ruled that all of Plaintiff’s expert’s opinions were inadmissible under Daubert and that Plaintiff’s claims could not proceed in the absence of admissible expert support. Judge Pregerson dismissed the case in its entirety. Northrup v. Covidien had been set to go to trial …
ICYMI: Wilkinson Stekloff Partner Ralia E. Polechronis Featured in “How I Made Partner” Series
WASHINGTON, D.C. – Wilkinson Stekloff partner Ralia E. Polechronis has been featured in ALM’s “How I Became Partner” series, which highlights how some of the most prominent lawyers in the field climbed to top positions in the legal world and imparts their advice to newcomers in the legal profession. Ralia on the stellar partnership at Wilkinson Stekloff: “Partnership is very much a two-way street—you have to perform, but you also need those already there to cheer you on.” – Ralia Polechronis. Ralia’s advice to young associates who want to become partner: “Put yourself out there. Take risks and ask questions. Treat each assignment—no matter how mundane—as the most important task for your team and your client. Make yourself indispensable. If you are the person partners and your peers go to for the answers, you are doing something right. Finally, and this is just as important as the other advice, give …
Wilkinson Stekloff Partners Moira Penza and Ralia Polechronis Awarded Notable Women in Law by Crain’s New York Business
Washington, D.C. – Crain’s New York Business has named Wilkinson Stekloff partners Moira Penza and Ralia Polechronis to its Crain’s New York Business 2021 “Notable Women in Law” list. Crain’s selected attorneys based on their skills, sense of justice, and professional achievements. Moira and Ralia were also recognized for their pro bono work and commitment to helping their communities. Crain’s highlighted Moira’s high-profile litigation practice which builds upon her resume as a former Assistant U.S. Attorney for the Eastern District of New York. Crain’s explained, “She’s been fielding an independent review of the Washington Football Team’s policies amid allegations of workplace misconduct. . .She’s also representing Altria in a series of. . .lawsuits arising out of its investment in Juul.” “I am honored to be recognized for my high-profile litigation experience and for the key role Wilkinson Stekloff plays in pro bono advocacy,” said Wilkinson Stekloff Partner Moira Penza. “It …
Wilkinson Stekloff Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers
WASHINGTON –Wilkinson Stekloff enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.
Wilkinson Stekloff Announces Three Promotions
WASHINGTON — Wilkinson Stekloff today announced three promotions. Kieran Gostin and Ralia Polechronis were elected to the partnership, and Andrew Croner was promoted to counsel. The promotions took effect on June 1. “Kieran, Ralia, and Andrew have each in their own ways played an integral role in many of the firm’s successes, from inside the courtroom to mentoring fellow colleagues,” said founding partner Alex Walsh. “We are truly fortunate to have them in the Wilkinson Stekloff family. Their well-deserved promotions are a testament to their value to the firm.” An experienced defense attorney, Kieran has represented government and corporate clients in products liability, antitrust, data breach, copyright, national security, First Amendment, Privacy Act, Administrative Procedure Act, and other complex civil litigation matters. Kieran recently helped lead a trial team that won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit (Farar et al. v. Bayer) …
Wilkinson Stekloff Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers
WASHINGTON – Wilkinson Stekloff is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Stekloff’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Stekloff won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Stekloff, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Stekloff, led by Kosta Stojilkovic …
- Page 2 of 2
- 1
- 2
